SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898430-98-001559
Filing Date
1998-04-24
Accepted
1998-04-24 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND L P ET ALBVF INC.BVF PARTNERS L.P.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT #1 SC 13D/A 16817
2 AGREEMENT REGARDING JOINT FILING EX-99.A 1286
3 TRANSACTIONS IN THE STOCK BY THE REPORTING PERSONS EX-99.B 2349
  Complete submission text file 0000898430-98-001559.txt   22830
Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 505 COAST BLVD SOUTH SUITE 300 LA JOLLA CA 92037
Business Address 505 COAST BLVD SOUTH STE 300 LA JOLLA CA 92037 6194525892
SIBIA NEUROSCIENCES INC (Subject) CIK: 0001011065 (see all company filings)

IRS No.: 953616229 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48087 | Film No.: 98600707
SIC: 2834 Pharmaceutical Preparations